Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 22 | 2024 | 232 | 3.090 |
Why?
|
| Plasmodium falciparum | 22 | 2024 | 254 | 2.550 |
Why?
|
| Antimalarials | 12 | 2024 | 125 | 1.930 |
Why?
|
| Drug Resistance | 12 | 2024 | 152 | 1.560 |
Why?
|
| Introns | 2 | 2026 | 111 | 1.110 |
Why?
|
| Complement C4a | 1 | 2026 | 4 | 0.960 |
Why?
|
| HLA-DR alpha-Chains | 1 | 2026 | 7 | 0.960 |
Why?
|
| Celiac Disease | 1 | 2026 | 19 | 0.940 |
Why?
|
| Malaria | 5 | 2024 | 156 | 0.850 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2026 | 509 | 0.820 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2026 | 733 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2026 | 630 | 0.650 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 312 | 0.570 |
Why?
|
| Stress, Physiological | 2 | 2026 | 209 | 0.390 |
Why?
|
| Uganda | 8 | 2024 | 38 | 0.380 |
Why?
|
| Mutation | 4 | 2020 | 2659 | 0.380 |
Why?
|
| Folic Acid Antagonists | 2 | 2022 | 8 | 0.350 |
Why?
|
| Haplotypes | 4 | 2026 | 134 | 0.350 |
Why?
|
| Democratic Republic of the Congo | 4 | 2020 | 19 | 0.260 |
Why?
|
| Sulfadoxine | 4 | 2020 | 15 | 0.260 |
Why?
|
| Genome, Protozoan | 2 | 2024 | 14 | 0.260 |
Why?
|
| Child | 5 | 2026 | 4614 | 0.250 |
Why?
|
| RNA Precursors | 1 | 2026 | 78 | 0.230 |
Why?
|
| Humans | 27 | 2026 | 64908 | 0.230 |
Why?
|
| Alternative Splicing | 1 | 2026 | 138 | 0.220 |
Why?
|
| Plasmodium ovale | 1 | 2024 | 10 | 0.220 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.220 |
Why?
|
| Bacillus thuringiensis | 1 | 2024 | 21 | 0.220 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 16 | 0.210 |
Why?
|
| Protozoan Proteins | 5 | 2024 | 132 | 0.210 |
Why?
|
| Proviruses | 1 | 2024 | 27 | 0.210 |
Why?
|
| Hemolysin Proteins | 1 | 2024 | 45 | 0.210 |
Why?
|
| Endotoxins | 1 | 2024 | 81 | 0.210 |
Why?
|
| Artemisinins | 2 | 2021 | 42 | 0.200 |
Why?
|
| Parasites | 1 | 2023 | 15 | 0.200 |
Why?
|
| Thermogenesis | 1 | 2024 | 127 | 0.200 |
Why?
|
| Culicidae | 1 | 2023 | 14 | 0.200 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 124 | 0.200 |
Why?
|
| RNA, Viral | 1 | 2024 | 266 | 0.190 |
Why?
|
| Genotype | 5 | 2024 | 673 | 0.190 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 32 | 0.190 |
Why?
|
| Adolescent | 5 | 2026 | 6305 | 0.190 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 52 | 0.170 |
Why?
|
| Aminoquinolines | 1 | 2021 | 16 | 0.170 |
Why?
|
| Naphthoquinones | 1 | 2021 | 4 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2024 | 533 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 235 | 0.170 |
Why?
|
| Pyrimethamine | 4 | 2022 | 20 | 0.160 |
Why?
|
| Chloroquine | 4 | 2021 | 57 | 0.160 |
Why?
|
| Drug Combinations | 4 | 2021 | 166 | 0.160 |
Why?
|
| Young Adult | 3 | 2026 | 4784 | 0.160 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 447 | 0.150 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 74 | 0.150 |
Why?
|
| Genome, Viral | 1 | 2020 | 144 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 104 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 744 | 0.150 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 348 | 0.140 |
Why?
|
| HIV-1 | 1 | 2024 | 705 | 0.140 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 198 | 0.140 |
Why?
|
| Microsatellite Repeats | 1 | 2018 | 42 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2024 | 829 | 0.140 |
Why?
|
| Tanzania | 3 | 2024 | 40 | 0.130 |
Why?
|
| Whole Genome Sequencing | 3 | 2024 | 84 | 0.130 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 706 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2018 | 210 | 0.130 |
Why?
|
| Female | 7 | 2026 | 33853 | 0.130 |
Why?
|
| Male | 6 | 2026 | 30894 | 0.120 |
Why?
|
| Genetic Variation | 3 | 2024 | 393 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 47 | 0.110 |
Why?
|
| Adult | 4 | 2026 | 17282 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2026 | 85 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2015 | 325 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1216 | 0.100 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 2024 | 22 | 0.100 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2024 | 14 | 0.090 |
Why?
|
| Zambia | 2 | 2023 | 19 | 0.090 |
Why?
|
| Prevalence | 3 | 2021 | 1437 | 0.090 |
Why?
|
| Proguanil | 2 | 2022 | 6 | 0.090 |
Why?
|
| Drosophila | 1 | 2015 | 481 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2023 | 122 | 0.090 |
Why?
|
| Infant | 3 | 2020 | 1688 | 0.090 |
Why?
|
| Geography | 2 | 2021 | 36 | 0.080 |
Why?
|
| Genomics | 2 | 2024 | 384 | 0.080 |
Why?
|
| Animals | 6 | 2026 | 21339 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2020 | 2059 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2759 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 757 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2697 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1223 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 709 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1276 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2026 | 10 | 0.060 |
Why?
|
| Exons | 1 | 2026 | 205 | 0.060 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 19 | 0.060 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2024 | 24 | 0.050 |
Why?
|
| Insecticide Resistance | 1 | 2024 | 11 | 0.050 |
Why?
|
| Metagenomics | 1 | 2024 | 29 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 29 | 0.050 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2024 | 13 | 0.050 |
Why?
|
| Karyopherins | 1 | 2024 | 10 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2024 | 52 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2026 | 222 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2026 | 3150 | 0.050 |
Why?
|
| Piperazines | 1 | 2024 | 86 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 3303 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2023 | 12 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 386 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 197 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2026 | 962 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 27 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2023 | 29 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 125 | 0.050 |
Why?
|
| Ethylenediamines | 1 | 2022 | 2 | 0.050 |
Why?
|
| Asparagine | 1 | 2022 | 25 | 0.050 |
Why?
|
| Sulfones | 1 | 2022 | 43 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2026 | 391 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 134 | 0.050 |
Why?
|
| Ethiopia | 1 | 2021 | 8 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 204 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 439 | 0.040 |
Why?
|
| Mice | 2 | 2026 | 11113 | 0.040 |
Why?
|
| Liver | 1 | 2026 | 867 | 0.040 |
Why?
|
| Cytochromes b | 1 | 2021 | 4 | 0.040 |
Why?
|
| Atovaquone | 1 | 2021 | 5 | 0.040 |
Why?
|
| Cambodia | 1 | 2021 | 28 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2022 | 198 | 0.040 |
Why?
|
| Antigens, Protozoan | 1 | 2021 | 63 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2021 | 90 | 0.040 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2020 | 11 | 0.040 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2020 | 19 | 0.040 |
Why?
|
| Parasitemia | 1 | 2020 | 49 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2020 | 34 | 0.040 |
Why?
|
| Kenya | 1 | 2020 | 97 | 0.040 |
Why?
|
| Ghana | 1 | 2020 | 14 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 311 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 64 | 0.040 |
Why?
|
| Islands | 1 | 2020 | 2 | 0.040 |
Why?
|
| Haploidy | 1 | 2020 | 13 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2019 | 6 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Travel | 1 | 2020 | 43 | 0.040 |
Why?
|
| Gene Library | 1 | 2020 | 102 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 256 | 0.040 |
Why?
|
| Demography | 1 | 2020 | 178 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 231 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 414 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 138 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 590 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2020 | 271 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 755 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 360 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 1560 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 1232 | 0.030 |
Why?
|
| HIV Infections | 1 | 2024 | 955 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2024 | 1551 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1413 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 158 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 95 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 81 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 300 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2366 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2609 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 661 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1572 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 1597 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 18166 | 0.010 |
Why?
|